146
Participants
Start Date
December 31, 2010
Primary Completion Date
January 31, 2013
Study Completion Date
March 31, 2013
Experimental Bapineuzumab
Bapineuzumab 2 mg, Bapineuzumab 7 mg, Bapineuzumab 20 mg, Placebo
Janssen AI Investigational Site, Latham
Janssen AI Investigational Site, Philadelphia
Janssen AI Investigational Site, Winston-Salem
Janssen AI Investigational Site, Atlanta
Janssen AI Investigational Site, Deerfield Beach
Janssen AI Investigational Site, South Miami
Janssen AI Investigational Site, Miami Springs
Janssen AI Investigational Site, Delray Beach
Janssen AI Investigational Site, Fort Meyers
Janssen AI Investigational Site, Lexington
Janssen AI Investigational Site, Dayton
Janssen AI Investigational Site, Indianapolis
Janssen AI Investigational Site, Farmington Hills
Janssen AI Investigational Site, St Louis
Janssen AI Investigational Site, Creve Coeur
Janssen AI Investigational Site, Kansas City
Janssen AI Investigational Site, Tucson
Janssen AI Investigational Site, Tucson
Janssen AI Investigational Site, Lomita
Janssen AI Investigational Site, Santa Monica
Janssen AI Investigational Site, La Habra
Janssen AI Investigational Site, Long Beach
Janssen AI Investigational Site, Pasadena
Janssen AI Investigational Site, Sherman Oaks
Janssen AI Investigational Site, Oceanside
Janssen AI Investigational Site, Portland
Janssen AI Investigational Site, Plymouth
Janssen AI Investigational Site, Providence
Collaborators (1)
Pfizer
INDUSTRY
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
INDUSTRY